Clear Blue Technologies Stock (OTC: CBUTF)

Latest News for Clear Blue Technologies Stock (OTC:CBUTF)

Clear Blue Technologies International Inc is engaged in the business of developing and selling Smart Off-Grid power solutions and management services to the power, control, monitor, manage, and proactively service solar and hybrid-powered systems such as street lights, security systems, telecommunications systems, emergency power, and Internet of Things (IoT) devices. The Company operates in three geographical areas: Canada, the United States of America, and the Middle East, and Africa.

CLEAR BLUE TECH INTL INC by CLEAR BLUE TECHNOLOGIES INTL INC.

Clear Blue Technologies International Inc

Applied Industrial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) reported quarterly earnings of $2.48 per share which beat the analyst consensus estimate of $2.41 by 2.9 percent. This is a 0.4 percent increase over earnings of $2.47 per share from the same period last year. The company reported quarterly sales of $1.146 billion which beat the analyst consensus estimate of $1.132 billion by 1.25 percent. This is a 1.24 percent increase over sales of $1.132 billion the same period last year.

Earnings

Earnings Beats

News

Applied Industrial Q3 2024 GAAP EPS $2.48 Beats $2.41 Estimate, Sales $1.146B Beat $1.132B Estimate

2024&nbsp;Guidance
Mrs. de Vet-Veithen concluded, &quot;The fundamentals of our three business segments are strong and we remain confident that we are well positioned to deliver on our growth objectives. We continue to expect to report consolidated revenue for the full fiscal year 2024 within the 265,000 to 275,000 kEUR range we communicated in our year-end 2023 earnings announcement in February 2024. We are also maintaining our Adjusted EBIT&nbsp;guidance&nbsp;of 11,000 kEUR to 14,000 kEUR for fiscal year 2024.&quot;

Guidance

MTLS

Materialise Reiterated FY24 Revenue of €265M-€275M

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Gain Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GANX#NASDAQ">GANX</a>) with a Buy and maintains $9 price target.

Price Target

Reiteration

Analyst Ratings

GANX

HC Wainwright & Co. Reiterates Buy on Gain Therapeutics, Maintains $9 Price Target

WEX Raises FY24 Revenue Outlook From $2.70B-$2.74B To $2.73B-$2.77B (Est $2.735B), Adjusted EPS From $15.90-$16.40 To $16.10-$16.60 (Est $16.25)

Transunion Sees Q2 Adj. EPS $0.95-$0.98 vs $0.90 Est., Revenue $1.017B-$1.026B vs $1.01B Est.

CMS Energy Reaffirmed FY24 Adj. EPS Guidance At $3.29-$3.35 (Est. $3.33) And Long-Term Adj. EPS Growth Of 6%-8%, With Continued Confidence Toward High End

CBIZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBZ#NYSE">CBZ</a>) reported quarterly earnings of $1.54 per share which beat the analyst consensus estimate of $1.50 by 2.67 percent. This is a 5.48 percent increase over earnings of $1.46 per share from the same period last year. The company reported quarterly sales of $494.30 million which beat the analyst consensus estimate of $490.88 million by 0.70 percent. This is a 8.73 percent increase over sales of $454.61 million the same period last year.

CBIZ Q1 Adj $1.54 Beats $1.50 Estimate, Sales $494.30M Beat $490.88M Estimate

CARR

Carrier Sees 024 Adj. Operating Margin ~15.5%; Lowers Sales Guidance From ~$26.5B To ~$26B vs $26.22B Est., Reaffirms Adj. EPS Guidance $2.80-$2.90 vs $2.84 Est.

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Lantern Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRN#NASDAQ">LTRN</a>) with a Neutral.

LTRN

HC Wainwright & Co. Reiterates Neutral on Lantern Pharma

Amalgamated Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAL#NASDAQ">AMAL</a>) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.74 by 12.16 percent. This is a 12.16 percent increase over earnings of $0.74 per share from the same period last year. The company reported quarterly sales of $78.266 million which beat the analyst consensus estimate of $75.891 million by 3.13 percent. This is a 7.97 percent increase over sales of $72.488 million the same period last year.

AMAL

Amalgamated Financial Q1 2024 Adj EPS $0.83 Beats $0.74 Estimate, Sales $78.266M Beat $75.891M Estimate

Gorman-Rupp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRC#NYSE">GRC</a>) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.34 by 11.76 percent. This is a 11.11 percent increase over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $159.27 million which missed the analyst consensus estimate of $168.24 million by 5.33 percent. This is a 0.75 percent decrease over sales of $160.47 million the same period last year.

Earnings Misses

Gorman-Rupp Q1 Adj $0.30 Misses $0.34 Estimate, Sales $159.27M Miss $168.24M Estimate

Materialise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTLS#NASDAQ">MTLS</a>) reported quarterly earnings of $0.07 per share. The company reported quarterly sales of $68.798 million which beat the analyst consensus estimate of $62.700 million by 9.73 percent. This is a 3.98 percent decrease over sales of $71.651 million the same period last year.

Materialise Q1 2024 GAAP EPS $0.07, Sales $68.798M Beat $62.700M Estimate

WEX Expects Q2 Revenue Of $675M-$685M (Est $678.959M) And Adjusted EPS Of $3.75-$3.85 (Est $3.98)

Precision Drilling (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PDS#NYSE">PDS</a>) reported quarterly earnings of $1.88 per share which missed the analyst consensus estimate of $2.63 by 28.63 percent. The company reported quarterly sales of $391.580 million which missed the analyst consensus estimate of $530.500 million by 26.19 percent. This is a 5.23 percent decrease over sales of $413.211 million the same period last year.

Precision Drilling Q1 2024 GAAP EPS $1.88 Misses $2.63 Estimate, Sales $391.580M Miss $530.500M Estimate

Insteel Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIIN#NYSE">IIIN</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.29 by 20.69 percent. The company reported quarterly sales of $127.394 million which missed the analyst consensus estimate of $134.893 million by 5.56 percent. This is a 19.90 percent decrease over sales of $159.051 million the same period last year.

IIIN

Insteel Indus Q2 2024 GAAP EPS $0.35 Beats $0.29 Estimate, Sales $127.394M Miss $134.893M Estimate

Biotech

Large Cap

Health Care

General

Merck Forecasts 2024 Adjusted EPS Of $8.53-$8.65 Versus Prior Guidance Of $8.44-$8.59 And Consensus Of $8.56

A Russian missile strike has caused severe damage to civilian and railway infrastructure in Ukraine&#8217;s Cherkasy region, injuring six people.
What Happened: The attack, which occurred on Thursday, hit the city of Smila, causing significant damage to civilian and railway infrastructure, Reuters reported. The strike was carried out using an Iskander-K missile, according to Ukrainian Air Force spokesperson Illya Yevlash.
The attack also resulted in damage to 47 private residences and shattered windows in a residential high-rise building, said Cherkasy Governor Ihor Taburets. The Ukrainian air defenses successfully intercepted the aerial target, and emergency services are currently working at the site.
This is not the first time that Russian forces have targeted Ukraine&#8217;s railway infrastructure. On Apr. 19, a strike in the Dnipro region caused significant damage, as reported by Ukraine&#8217;s national railways Ukrzaliznytsia on Telegram.
See Also: <a href="https://www.benzinga.com/news/24/04/38368085/what-happens-if-trump-gets-convicted-will-he-go-to-prison-heres-how-it-likely-to-play-out?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">What Happens If Trump Gets Convicted? Will He Go To Prison? — Here&#8217;s How It&#8217;s Likely To Play Out</a>
Why It Matters: The missile strike comes amid escalating tensions between Russia and the West over the Ukraine conflict. The West has been considering various measures to support Ukraine, including the potential seizure of Russian assets.
On Tuesday, a key ally of Russian President Vladimir Putin <a href="https://www.benzinga.com/news/24/04/38376263/russia-threatens-retaliation-over-potential-seizure-of-frozen-assets-to-aid-ukraine">warned of severe retaliation</a> if the West proceeds with the seizure of nearly $300 billion of frozen Russian assets to aid Ukraine. The proposal to seize these assets is still under discussion among Western officials.
Meanwhile, the European Union&#8217;s top diplomat in Asia has <a href="https://www.benzinga.com/news/24/04/38373137/eus-top-diplomat-in-asia-warns-china-over-russia-ties-trade-imbalance-we-have-to-stand-up-for-oursel">warned China</a> that its support for Russia and significant trade surplus with the EU are major obstacles to improved relations. The U.S. is also considering imposing <a href="https://www.benzinga.com/markets/asia/24/04/38380008/us-mulls-sanctions-on-beijing-banks-for-alleged-role-in-putins-war-in-ukraine-china-cant-have-it-bot">sanctions on certain Chinese banks</a> over their commercial support of Russia&#8217;s war in Ukraine.
Amid these tensions, the Kremlin has <a href="https://www.benzinga.com/24/04/38349780/russia-foresees-humiliating-fiasco-for-us-in-ukraine-support-kremlin-drops-vietnam-and-afghanistan-r">issued a warning</a> that the U.S.&#8217;s support for Ukraine could lead to a &#8220;humiliating fiasco,&#8221; drawing parallels with Vietnam and Afghanistan. Amid this, the U.S. Congress has approved a <a href="https://www.benzinga.com/news/24/04/38395838/us-congress-finally-passes-95b-foreign-aid-bill-for-ukraine-israel-taiwan-amid-simmering-russian-agg">comprehensive $95 billion aid package</a>, with $61 billion allocated to Ukraine.
Read Next: <a href="https://www.benzinga.com/general/politics/24/04/38362005/donald-trump-may-soon-receive-36-million-more-djt-shares-key-milestone-ahead?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Donald Trump May Soon Receive An Additional $1.26B In DJT Shares: Key Milestone Ahead </a>
Image Via Shutterstock 
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Kaustubh Bagalkote</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/topic/kaustubh-bagalkote" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

Politics

Global

Russian Missile Strike In Ukraine Injures Six, Damages Civilian Infrastructure

Needham analyst James Ricchiuti maintains Teledyne Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) with a Buy and lowers the price target from $510 to $455.

Needham Maintains Buy on Teledyne Technologies, Lowers Price Target to $455

WIIM

Royal Caribbean shares are trading higher after the company raised its 2024 adjusted EPS guidance above estimates and reported better-than-expected Q1 2024 financial results.

Strategic Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRA#NASDAQ">STRA</a>) reported quarterly earnings of $1.11 per share which beat the analyst consensus estimate of $0.59 by 88.14 percent. This is a 362.5 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $290.300 million which beat the analyst consensus estimate of $273.635 million by 6.09 percent. This is a 13.13 percent increase over sales of $256.606 million the same period last year.